Straits Times Index
3,077.26 +0.10 (+0.00%) Nikkei
33,445.90 +670.08 (+2.04%) Hang Seng
16,512.07 +184.21 (+1.13%) FTSE 100
7,489.84 -23.12 (-0.31%) Bitcoin USD
43,675.04 +1,995.65 (+4.79%) CMC Crypto 200
893.11 +32.57 (+3.78%)
NKE Jan 2025 190.000 put
| Previous close | 81.85 |
| Open | 81.85 |
| Bid | 79.05 |
| Ask | 81.90 |
| Strike | 190.00 |
| Expiry date | 2025-01-17 |
| Day's range | 81.85 - 81.85 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
- Yahoo Finance Video
Moody's cuts China credit outlook: Stocks with most exposure
Moody's cuts its credit outlook for China's government over rising debt, slowing economic growth, and risks in the nation's property sector. Yahoo Finance Reporter Madison Mills joins the Live show discussion on how China-exposed companies Nike (NKE), Tesla (TSLA), Caterpillar (CAT), and Apple (AAPL) have been reacting to a slowing Chinese economy and how their own performances have been reflected in the Chinese market. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
- Thomson Reuters StreetEvents
Q3 2023 Designer Brands Inc Earnings Call
Q3 2023 Designer Brands Inc Earnings Call
- Investing.com
Nike assumed at Buy, 'near-term challenges well understood': 4 big analyst picks
Here is your Pro Recap of the biggest analyst picks you may have missed since yesterday: Buy assumptions at Nike and Block, and upgrades at Crown Castle and Apellis Pharmaceuticals. Goldman Sachs assumed coverage on Nike (NYSE:NKE) with a Buy rating and a price target of $139.00 (from $136 prior), as reported in real-time on InvestingPro. The analysts expect an upturn in Nike's earnings growth.
